2024
Buprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles
Afranie-Sakyi J, Tiako M, Vasquez K, Van Doren L, Calhoun C. Buprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles. Blood 2024, 144: 3628. DOI: 10.1182/blood-2024-194039.Peer-Reviewed Original ResearchSickle cell disease providerSCD-related painSickle cell diseaseAdult providersOpioid use disorderPrescribing buprenorphineX-waiverOpioid agonistsPain managementChronic painPrescribing habitsPediatric providersInitiate buprenorphineAdvanced practice providersSCD agesHigh volume of patientsPain management guidelinesSide effectsOptimal pain managementDose-dependent adverse effectsDecreased quality of lifeCross-sectional studyPartial opioid agonistQuality of lifeChronic hemolytic anemia
2018
Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease
Calhoun C, Luo L, Baumann A, James A, King A. Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease. Blood 2018, 132: 2274. DOI: 10.1182/blood-2018-99-113150.Peer-Reviewed Original ResearchSickle cell diseaseDisease-specific knowledgePatient-provider communicationAdult careYoung adultsOccupational settingsDisease complicationsCell diseaseHealth knowledgeEmergency department providersTransitions of careHealth knowledge gapsQuality of lifeUse of diseaseAfrican AmericansCommon genetic conditionYoung adult periodProphylactic penicillinPneumococcal vaccinationLarge hospital systemHealthcare utilizationSCD patientsHigh morbidityED providersTreatment options